Meeting the Demands of a Changing Clinical Research Landscape
Leveraging an FSP model to support non-footprint countries provides greater resource flexibility and access to specific expertise not readily available in-house. This model is also growing in popularity, as the FSP market has grown substantially in recent years and is projected to continue at a compound annual growth rate of more than 7% from 2023 to 2027.
A 2023 survey of biopharma and biotech leaders conducted by PPD® also revealed an increase in FSP outsourcing over the past two years, with 41% of respondents reporting increased use of FSP models
Offered Free by: PPD
See All Resources from: PPD
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.